Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids
Curtis D. Klaassen, Julia Yue Cui
Drug Metabolism and Disposition (2015) Vol. 43, Iss. 10, pp. 1505-1521
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung, Zhipeng Li, Hannah You, et al.
EBioMedicine (2020) Vol. 51, pp. 102590-102590
Open Access | Times Cited: 1346
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
Janis R. Bedarf, Falk Hildebrand, Luís Pedro Coelho, et al.
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 521
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Ian D. Wilson, Jeremy K. Nicholson
Translational research (2016) Vol. 179, pp. 204-222
Open Access | Times Cited: 511
Bile Acids Activated Receptors Regulate Innate Immunity
Stefano Fiorucci, Michele Biagioli, Angela Zampella, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 414
Microbial modulation of cardiovascular disease
J. Mark Brown, Stanley L. Hazen
Nature Reviews Microbiology (2018) Vol. 16, Iss. 3, pp. 171-181
Open Access | Times Cited: 373
Bioaccumulation of therapeutic drugs by human gut bacteria
Martina Klünemann, Sergej Andrejev, Sonja Blasche, et al.
Nature (2021) Vol. 597, Iss. 7877, pp. 533-538
Open Access | Times Cited: 228
Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury
Bejan Saeedi, Ken Liu, Joshua A. Owens, et al.
Cell Metabolism (2020) Vol. 31, Iss. 5, pp. 956-968.e5
Open Access | Times Cited: 216
The Role of Gut Microbiota in Atherosclerosis and Hypertension
Junli Ma, Houkai Li
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 200
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice
Anuradha Rao, Astrid Kosters, Jamie E. Mells, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 357
Open Access | Times Cited: 190
Emerging issues in probiotic safety: 2023 perspectives
Daniel Merenstein, Bruno Pot, Gregory Leyer, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 188
The influence of the gut microbiota on the bioavailability of oral drugs
Xintong Zhang, Ying Han, Wei Huang, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 7, pp. 1789-1812
Open Access | Times Cited: 148
Antimicrobial Resistance and Its Spread Is a Global Threat
Mohammed Aljeldah
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1082-1082
Open Access | Times Cited: 148
Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
Lili Ding, Kyle M. Sousa, Lihua Jin, et al.
Hepatology (2016) Vol. 64, Iss. 3, pp. 760-773
Open Access | Times Cited: 166
Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Hollie I. Swanson
Drug Metabolism and Disposition (2015) Vol. 43, Iss. 10, pp. 1499-1504
Open Access | Times Cited: 151
Effects of single and combined toxic exposures on the gut microbiome: Current knowledge and future directions
John Tsiaoussis, Michael Antoniou, Ioannis Koliarakis, et al.
Toxicology Letters (2019) Vol. 312, pp. 72-97
Closed Access | Times Cited: 123
A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice
Jan Freark de Boer, Esther Verkade, Niels L. Mulder, et al.
Journal of Lipid Research (2019) Vol. 61, Iss. 3, pp. 291-305
Open Access | Times Cited: 121
Drug–gut microbiota interactions: implications for neuropharmacology
Jacinta Walsh, Brendan T. Griffin, Gerard Clarke, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 24, pp. 4415-4429
Open Access | Times Cited: 118
Gut microbiota and obesity: Concepts relevant to clinical care
Maria Carlota Dao, Karine Clément
European Journal of Internal Medicine (2017) Vol. 48, pp. 18-24
Open Access | Times Cited: 115
The influence of antibiotics and dietary components on gut microbiota
Ruth Dudek-Wicher, Adam Junka, Marzenna Bartoszewicz
Gastroenterology Review (2018) Vol. 13, Iss. 2, pp. 85-92
Open Access | Times Cited: 107
FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
Elliot S. Friedman, Yun Li, Ting‐Chin David Shen, et al.
Gastroenterology (2018) Vol. 155, Iss. 6, pp. 1741-1752.e5
Open Access | Times Cited: 106
Models for drug absorption from the small intestine: where are we and where are we going?
Pierre‐André Billat, Emilie Roger, Sébastien Faure, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 5, pp. 761-775
Open Access | Times Cited: 105
The Liver at the Nexus of Host-Microbial Interactions
Andrew J. Macpherson, Mathias Heikenwälder, Stephanie C. Ganal‐Vonarburg
Cell Host & Microbe (2016) Vol. 20, Iss. 5, pp. 561-571
Open Access | Times Cited: 102
Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine
Said R. Bogatyrev, Justin C. Rolando, Rustem F. Ismagilov
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 94
Gut Microbiota in Intestinal and Liver Disease
Rheinallt M. Jones, Andrew S. Neish
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 251-275
Closed Access | Times Cited: 89
Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice
Takuya Kuno, Mio Hirayama‐Kurogi, Shingo Ito, et al.
Molecular Pharmaceutics (2016) Vol. 13, Iss. 8, pp. 2691-2701
Closed Access | Times Cited: 86
Page 1 - Next Page

Scroll to top